These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 17954156)

  • 1. The influence of HLA mismatches and immunosuppression on kidney graft survival: an analysis of more than 1300 patients.
    Martins L; Fonseca I; Sousa S; Matos C; Santos J; Dias L; Henriques AC; Sarmento AM; Cabrita A
    Transplant Proc; 2007 Oct; 39(8):2489-93. PubMed ID: 17954156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of immunosuppressive regimens on graft survival and secondary outcomes after kidney transplantation.
    Opelz G; Döhler B;
    Transplantation; 2009 Mar; 87(6):795-802. PubMed ID: 19300179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA mismatches remain risk factors for acute kidney allograft rejection in patients receiving quadruple immunosuppression with anti-interleukin-2 receptor antibodies.
    Wissing KM; Fomegné G; Broeders N; Ghisdal L; Hoang AD; Mikhalski D; Donckier V; Vereerstraeten P; Abramowicz D
    Transplantation; 2008 Feb; 85(3):411-6. PubMed ID: 18322434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-center analysis of 468 first cadaveric kidney allografts with a uniform ATG-CsA sequential therapy.
    Giral M; Taddei C; Nguyen JM; Dantal J; Hourmant M; Cantarovich D; Blancho G; Ancelet D; Soulillou JP
    Clin Transpl; 1996; ():257-64. PubMed ID: 9286575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and socioeconomic benefits of serological HLA-DR matching for renal transplantation over three eras of immunosuppression regimens at a single unit.
    Taylor CJ; Welsh KI; Gray CM; Bunce M; Bayne AM; Sutton PM; Gray DW; Ting A; Morris PJ
    Clin Transpl; 1993; ():233-41. PubMed ID: 7918156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppression modifications and graft outcome in patients with chronic allograft nephropathy.
    El-Agroudy AE; El-Dahshan K; Mahmoud K; Ismail AM; El-Baz M; Shokeir AA; Ghoneim MA
    Exp Clin Transplant; 2008 Sep; 6(3):203-10. PubMed ID: 18954298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute rejection in cadaveric renal transplantation under cyclosporine based therapy. Analysis of the risk factors and its influence on chronic dysfunction].
    Mota A
    Acta Med Port; 2004; 17(1):8-14. PubMed ID: 15636737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter analysis of the significance of HLA matching on outcomes after kidney-pancreas transplantation.
    Lo A; Stratta RJ; Alloway RR; Hodge EE;
    Transplant Proc; 2005 Mar; 37(2):1289-90. PubMed ID: 15848699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human leukocyte antigen mismatches associated with increased risk of rejection, graft failure, and death independent of initial immunosuppression in renal transplant recipients.
    Lim WH; Chadban SJ; Clayton P; Budgeon CA; Murray K; Campbell SB; Cohney S; Russ GR; McDonald SP
    Clin Transplant; 2012; 26(4):E428-37. PubMed ID: 22672477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organ sharing for good HLA-A,B, and DR matching improves cadaver renal graft survival in SEOPF: retrospective and prospective studies considering delayed graft function, race, center effects, cyclosporine, and other factors.
    Sanfilippo F; Vaughn WK; Alexander JW; LeFor WM; Lucas BA; Pfaff WW
    Clin Transpl; 1988; ():211-23. PubMed ID: 3154474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of initial immunosuppression on long-term kidney transplant outcome in immunological low-risk patients.
    Michielsen LA; van Zuilen AD; Verhaar MC; Wisse BW; Kamburova EG; Joosten I; Allebes WA; van der Meer A; Baas MC; Spierings E; Hack CE; van Reekum FE; Bots ML; Drop ACAD; Plaisier L; Seelen MAJ; Sanders JF; Hepkema BG; Lambeck AJ; Bungener LB; Roozendaal C; Tilanus MGJ; Voorter CE; Wieten L; van Duijnhoven EM; Gelens MACJ; Christiaans MHL; van Ittersum FJ; Nurmohamed SA; Lardy NM; Swelsen W; van der Pant KA; van der Weerd NC; Ten Berge IJM; Bemelman FJ; Hoitsma A; van der Boog PJM; de Fijter JW; Betjes MGH; Heidt S; Roelen DL; Claas FH; Otten HG; Hilbrands LB
    Nephrol Dial Transplant; 2019 Aug; 34(8):1417-1422. PubMed ID: 30561730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of donor/recipient HLA-matching on outcome and recurrence of hepatitis C after liver transplantation.
    Langrehr JM; Puhl G; Bahra M; Schmeding M; Spinelli A; Berg T; Schönemann C; Krenn V; Neuhaus P; Neumann UP
    Liver Transpl; 2006 Apr; 12(4):644-51. PubMed ID: 16555324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spanish experience with cyclosporine.
    Pascual J; Marcén R; Burgos FJ; Villafruela JJ; Teruel JL; Mampaso F; Quereda C; Ortuño J
    Transplant Proc; 2004 Mar; 36(2 Suppl):117S-119S. PubMed ID: 15041319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cold ischemia is a major determinant of acute rejection and renal graft survival in the modern era of immunosuppression.
    Mikhalski D; Wissing KM; Ghisdal L; Broeders N; Touly M; Hoang AD; Loi P; Mboti F; Donckier V; Vereerstraeten P; Abramowicz D
    Transplantation; 2008 Apr; 85(7 Suppl):S3-9. PubMed ID: 18401260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance immunosuppression.
    Takemoto SK
    Clin Transpl; 2000; ():481-95. PubMed ID: 11512360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of mismatching and sharing of HLA-A, -B, and -DR antigens on kidney graft survival in Eurotransplant 1982 to 1988.
    Persijn GG; D'Amaro J; De Lange P; Schreuder GM; Thorogood J; Zantvoort F; Van Rood JJ
    Clin Transpl; 1988; ():237-48. PubMed ID: 3154476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of graft nephrectomy in pre-cyclosporine and cyclosporine era.
    Adhikary SD; Viswaroop SB; Kekre NS; Gopalakrishnan G
    Urol Int; 2008; 80(1):80-3. PubMed ID: 18204239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of mycophenolate mofetil and HLA matching on renal allograft survival.
    Meier-Kriesche HU; Ojo AO; Leichtman AB; Magee JC; Rudich SM; Hanson JA; Cibrik DM; Kaplan B
    Transplantation; 2001 Feb; 71(3):398-401. PubMed ID: 11233900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of HLA matching on survival in heart transplantation.
    Almenar L; Maeso ML; Martínez-Dolz L; Rueda J; Palomar CG; Sáez AO; Vives MA; Tort MD; Pérez MP
    Transplant Proc; 2005 Nov; 37(9):4001-5. PubMed ID: 16386610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.